Orexin Neuron Induction via N-acetyl-D-mannosamine Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively induce orexin neurons, which are crucial for regulating wakefulness and sleep, leading to limitations in treating narcolepsy and other related disorders, as existing therapies rely on orexin agonists or antagonists that are less effective without sufficient orexin-producing cells.
Innovation Solution
The method involves culturing pluripotent stem cells or neural progenitor cells in the presence of N-acetyl-D-mannosamine, either alone or combined with Sirtuin and O-linked β-N-acetylglucosamine transferase inhibitors, to induce orexin neurons, thereby increasing orexin gene expression and production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If orexin agonists or antagonists are used for treatment, then wakefulness-sleep regulation is improved, but effectiveness is limited due to insufficient orexin-producing cells
Solution Approach 1:
The patent applies preliminary action by inducing orexin neurons from pluripotent stem cells or neural progenitor cells before administering orexin agonists or antagonists. This pre-induction ensures sufficient orexin-producing cells are available to respond effectively to the pharmacological treatment, thereby resolving the limitation of insufficient target cells that previously reduced treatment effectiveness
2Productivity
If N-acetyl-D-mannosamine is added to culture medium, then orexin neuron induction is improved, but culture system complexity increases
Solution Approach 1:
The patent applies parameter changes by adding N-acetyl-D-mannosamine to the culture medium, which chemically modifies the nutritional parameters available to the cells. This simple chemical addition triggers metabolic pathways that lead to enhanced orexin neuron induction from pluripotent stem cells or neural progenitor cells, improving productivity without requiring complex mechanical or biological modifications to the culture system
Data Source
AI summary
The invention provides a method for producing an orexin neuron by culturing a pluripotent stem cell or a neural progenitor cell in the presence of N-acetyl-D-mannosamine and optionally in the presence of at least one inhibitor selected from the group consisting of a Sirtuin 1 inhibitor and an O-linked β-N-acetylglucosamine transferase inhibitor. The invention also provides a therapeutic agent for narcolepsy or eating disorders, such as anorexia, containing N-acetyl-D-mannosamine, which is based on the induction of orexin neuron in vivo.